Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials

Malignant Mesothelioma: Development to Therapy

(2013) Joyce K. Thompson et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Joint models for predicting transplant-related mortality from quality of life data

(2013) Norma Terrin et al.   QUALITY OF LIFE RESEARCH

Assessment of PRO Label Claims Granted by the FDA as Compared to the EMA (2006–2010)

(2013) Carla DeMuro et al.   VALUE IN HEALTH

Multilevel Bayesian Models for Survival Times and Longitudinal Patient-Reported Outcomes With Many Zeros

(2012) Laura A. Hatfield et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Patients’ preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis

(2012) John F.P. Bridges et al.   LUNG CANCER

Joint Modeling of Multiple Longitudinal Patient-Reported Outcomes and Survival

(2011) Laura A. Hatfield et al.   Journal of Biopharmaceutical Statistics

Sample size and power determination in joint modeling of longitudinal and survival data

(2011) Liddy M. Chen et al.   STATISTICS IN MEDICINE

Basic Concepts and Methods for Joint Models of Longitudinal and Survival Data

(2010) Joseph G. Ibrahim et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report

(2009) Margaret Rothman et al.   VALUE IN HEALTH

Joint modeling longitudinal semi-continuous data and survival, with application to longitudinal medical cost data

(2008) Lei Liu   STATISTICS IN MEDICINE